In addition to novel therapies and precision treatments, an in-depth exploration of the mechanisms of PD1/PD-L1 in ccRCC is crucial, as it holds significant implications for uncovering resistance mechanisms and optimizing treatment strategies. The gene discussed is CD274; the disease is nonpapillary renal cell carcinoma.